lisofylline has been researched along with 12-hydroxy-5,8,10,14-eicosatetraenoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarti, SK; Ma, K; Nadler, JL; Nunemaker, CS; Taylor-Fishwick, DA; Wu, R | 1 |
1 other study(ies) available for lisofylline and 12-hydroxy-5,8,10,14-eicosatetraenoic acid
| Article | Year |
|---|---|
12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Apoptosis; Arachidonate 12-Lipoxygenase; Cell Survival; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Pentoxifylline; Phosphorylation | 2010 |